HemaCare Corp. reported unaudited earnings results for the first six months ended June 30, 2016. For the period, revenue from continuing operations increased by 35% to $5.779 million compared to $4.294 million a year ago. Loss from continuing operations narrowed to $79,000 from $849,000. Loss from continuing operations before income taxes was $73,000 compared to $823,000 a year ago. Net loss was $79,000 compared to net income of $3,325,000 a year ago.